Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
970.87B | 998.78B | 892.78B | 962.88B | 782.91B | 569.76B | Gross Profit |
132.82B | 132.48B | 101.07B | 98.47B | 129.79B | 65.57B | EBIT |
57.09B | 54.61B | 31.38B | 17.21B | 59.52B | 11.14B | EBITDA |
94.62B | 95.17B | 67.91B | 54.50B | 93.56B | 44.54B | Net Income Common Stockholders |
32.03B | 27.98B | 13.86B | 4.70B | 32.05B | -3.27B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
36.55B | 26.33B | 40.20B | 22.34B | 14.33B | 28.09B | Total Assets |
1.02T | 970.01B | 914.43B | 860.10B | 828.73B | 732.96B | Total Debt |
366.16B | 349.55B | 320.90B | 364.21B | 362.63B | 361.57B | Net Debt |
329.61B | 323.22B | 280.70B | 341.87B | 348.30B | 333.48B | Total Liabilities |
675.39B | 650.42B | 612.38B | 590.84B | 581.14B | 536.51B | Stockholders Equity |
314.13B | 290.62B | 277.04B | 248.04B | 227.99B | 183.06B |
Cash Flow | Free Cash Flow | ||||
40.31B | -28.39B | 61.02B | 26.33B | -13.13B | 14.81B | Operating Cash Flow |
49.19B | 9.12B | 94.92B | 52.59B | 7.80B | 38.62B | Investing Cash Flow |
-9.41B | -36.87B | -36.20B | -26.93B | -21.04B | -20.95B | Financing Cash Flow |
-35.81B | 12.48B | -43.99B | -19.09B | -652.00M | -17.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥225.57B | 8.33 | 9.70% | 3.28% | 11.87% | 103.91% | |
51 Neutral | $2.04B | -1.21 | -21.10% | 3.95% | 2.90% | -30.45% | |
$1.92B | 10.70 | 6.92% | 0.02% | ― | ― | ||
$2.06B | 9.08 | 5.00% | 4.29% | ― | ― | ||
€603.96M | 7.86 | 5.42% | 4.52% | ― | ― | ||
€238.63M | 51.50 | 0.92% | 6.17% | ― | ― | ||
€483.80M | 4.23 | 14.23% | 3.30% | ― | ― |
UACJ Corporation announced corrections to its ‘Results Briefing for Fiscal 2024′ due to inaccuracies in previously disclosed financial figures. The corrections include adjustments to the consolidated cash flow figures, export volumes to U.S. customers, and sales volume forecasts, which may impact stakeholders’ understanding of the company’s financial health and market performance.
The most recent analyst rating on (JP:5741) stock is a Buy with a Yen5000.00 price target. To see the full list of analyst forecasts on UACJ stock, see the JP:5741 Stock Forecast page.
UACJ Corporation announced its fiscal 2024 business profit results at ¥45.9 billion, marking a year-on-year increase of ¥2.5 billion. The company forecasts a slight increase in business profit for fiscal 2025 to ¥46.0 billion, despite uncertainties in the global economy and potential tariff risks in the U.S. UACJ plans to increase its annual dividend to 160 yen per share, reflecting confidence in its steady market performance, particularly in the can stock sector.
The most recent analyst rating on (JP:5741) stock is a Buy with a Yen5000.00 price target. To see the full list of analyst forecasts on UACJ stock, see the JP:5741 Stock Forecast page.
UACJ Corporation reported a significant increase in its consolidated business performance for the fiscal year ended March 31, 2025, with a notable rise in revenue and profit attributable to owners of the parent. The company experienced an 11.9% increase in revenue and a 101.9% increase in profit attributable to owners of the parent compared to the previous year. Despite a decrease in total comprehensive income, the company improved its equity ratio and increased dividends, indicating a positive outlook for stakeholders.
The most recent analyst rating on (JP:5741) stock is a Buy with a Yen5000.00 price target. To see the full list of analyst forecasts on UACJ stock, see the JP:5741 Stock Forecast page.